[Should healthy carriers of HBs antigen be followed-up?].
Zylberberg
H
H
Unité d'Hépatologie, Hôpital Necker, Paris.
Pol
S
S
D006528:Carcinoma, Hepatocellular / Q000517:prevention & control; D002353:Carrier State / Q000503:physiopathology*; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000517:prevention & control; D006514:Hepatitis B Surface Antigens; D003699:Hepatitis D / Q000517:prevention & control; D006801:Humans; D008103:Liver Cirrhosis / Q000517:prevention & control; D008113:Liver Neoplasms / Q000517:prevention & control; D012307:Risk Factors; D013997:Time Factors
D006514:Hepatitis B Surface Antigens